Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. We are led by Dr. Vlad Coric, who was an OCD researcher and OCD treating physician at Yale University before joining the pharma industry and ultimately the CEO of Biohaven. Biohaven is a proud sponsor of the Orchard OCD Registry.

We are pleased to have received funding from the Hospital Saturday Fund towards our OCD patient registry.

 The Hospital Saturday Fund is a registered charity whose aims are to provide assistance for registered health charities, hospices, medical organisations and individuals with a medical condition or disability.